Avi Schroeder
Papers
2
Total Citations
114
H-Index
2
About
Avi Schroeder is a leading figure at the intersection of drug delivery, synthetic biology, and intelligent automation. His research focuses on engineering liposomes and polymeric systems for therapeutic applications, and he is pioneering the use of robotics, microfluidics, and nanotechnology to accelerate their synthesis and evaluation. Schroeder’s most cited work, a 2021 paper with 112 citations, demonstrates how AI and machine learning can streamline the design and testing of these complex drug carriers. More recently, he has pushed the boundaries of bottom-up synthetic biology, developing synthetic cells that can replace malfunctioning natural ones. His 2025 paper on scaling up synthetic cell production using robotics and machine learning—already garnering attention—outlines a path toward therapeutic applications with spatiotemporal control. By automating what were once manual, labor-intensive processes, Schroeder is not only advancing fundamental science but also making personalized, cell-based therapies more feasible and reproducible. His work exemplifies how interdisciplinary approaches can transform biomedical engineering.
Research Focus
Key Achievements
Top Papers
- 1
- 2